Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis

The estimated attributable mortality rate for invasive candidiasis (IC) in the intensive care unit (ICU) setting varies from 30 to 40%. Physiological changes in critically ill patients may affect the distribution and elimination of micafungin, and therefore, dosing adjustments might be mandatory. Th...

詳細記述

保存先:
書誌詳細
出版年:Antimicrob Agents Chemother
主要な著者: Boonstra, J. M., van der Elst, K. C., Veringa, A., Jongedijk, E. M., Brüggemann, R. J., Koster, R. A., Kampinga, G. A., Kosterink, J. G., van der Werf, T. S., Zijlstra, J. G., Touw, D. J., Alffenaar, J. W. C.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2017
主題:
Clinical Therapeutics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700342/
https://ncbi.nlm.nih.gov/pubmed/28971861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01398-17
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料